Europeans can now receive a device that can partially restore their vision loss. Americans may not have to wait long to get it, either.
Science Corporation announced Wednesday that European regulators had approved the commercial sale of the startup’s retinal implant that improves eyesight for patients with age-related macular degeneration in their central vision, enough to read books and road signs more clearly.
“We have a cochlear implant for vision now,” said Science founder and CEO Max Hodak.
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.
Already have an account? Log in
Individual plansGroup plans
To read the rest of this story subscribe to STAT+.